{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T09:22:16Z","timestamp":1767864136854,"version":"3.49.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejinme.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ejim.2017.08.016","type":"journal-article","created":{"date-parts":[[2017,8,15]],"date-time":"2017-08-15T08:15:49Z","timestamp":1502784949000},"page":"82-86","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients"],"prefix":"10.1016","volume":"47","author":[{"given":"Marco","family":"Contoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Pavasini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Marchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Pauletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Balla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Spanevello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6924-4500","authenticated-orcid":false,"given":"Alberto","family":"Papi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2017.08.016_bb0005","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS guidelines on myocardial revascularization","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ejim.2017.08.016_bb0010","author":"Global Initiative for Chronic Obstructive Lung Disease (GOLD)"},{"key":"10.1016\/j.ejim.2017.08.016_bb0015","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-2600(15)00241-6","article-title":"Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis","volume":"3","author":"Chen","year":"2015","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0020","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.ijcard.2016.08.030","volume":"222","author":"Campo","year":"2016","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0025","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2147\/COPD.S84482","article-title":"Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study","volume":"10","author":"Almagro","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ejim.2017.08.016_bb0030","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1378\/chest.12-2313","article-title":"Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention","volume":"144","author":"Campo","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2017.08.016_bb0035","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.amjcard.2010.03.026","article-title":"Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction","volume":"106","author":"Wakabayashi","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0040","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1164\/ajrccm.157.5.9709032","article-title":"Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease","volume":"157","author":"Seemungal","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0045","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1136\/thorax.57.10.847","article-title":"Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease","volume":"57","author":"Donaldson","year":"2002","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2017.08.016_bb0050","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.jaci.2010.01.003","article-title":"Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up","volume":"125","author":"Contoli","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0055","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalun","year":"2005","journal-title":"Thorax"},{"key":"10.1016\/j.ejim.2017.08.016_bb0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/138161207779313777","article-title":"Exacerbations of asthma and chronic obstructive pulmonary disease (COPD): focus on virus induced exacerbations","volume":"13","author":"Mallia","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejim.2017.08.016_bb0065","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0140-6736(07)61382-8","article-title":"COPD exacerbations: defining their cause and prevention","volume":"370","author":"Wedzicha","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.08.016_bb0070","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1183\/09031936.00180812","article-title":"Exacerbation of respiratory symptoms in COPD patients may not be exacerbations of COPD","volume":"41","author":"Beghe","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ejim.2017.08.016_bb0075","doi-asserted-by":"crossref","DOI":"10.3109\/15412555.2014.995293","article-title":"Relationship between troponin elevation, cardiovascular history and adverse events in patients with acute exacerbation of COPD","author":"Campo","year":"2015","journal-title":"COPD"},{"key":"10.1016\/j.ejim.2017.08.016_bb0080","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201306-1170OC","article-title":"Cardiovascular risk, myocardial injury and exacerbations of chronic obstructive pulmonary disease","author":"Patel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0085","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1378\/chest.09-2029","article-title":"Increased risk of myocardial infarction and stroke following exacerbation of COPD","volume":"137","author":"Donaldson","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.ejim.2017.08.016_bb0090","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1001\/archinternmed.2011.536","article-title":"Prognostic impact of hospital readmissions after primary percutaneous coronary intervention","volume":"171","author":"Campo","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0095","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1016\/j.amjcard.2005.01.096","article-title":"Comparison of effectiveness of sirolimus-eluting stents versus bare metal stents for percutaneous coronary intervention in patients at high risk for coronary restenosis or clinical adverse events","volume":"95","author":"Marzocchi","year":"2005","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0100","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjcard.2006.09.112","article-title":"Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes","volume":"99","author":"Salisbury","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0105","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(14)70008-6","article-title":"Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort","volume":"2","author":"Jones","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0110","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(07)61383-X","article-title":"From COPD to chronic systemic inflammatory syndrome?","volume":"370","author":"Fabbri","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.08.016_bb0115","doi-asserted-by":"crossref","first-page":"00037","DOI":"10.1183\/23120541.00037-2017","article-title":"Arterial stiffness in symptomatic smokers with normal lung function","volume":"3","author":"Scichilone","year":"2017","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.ejim.2017.08.016_bb0120","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-014-6569-y","article-title":"Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management","author":"Campo","year":"2015","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejim.2017.08.016_bb0125","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1160\/TH16-12-0973","article-title":"Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease","volume":"117","author":"Campo","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2017.08.016_bb0130","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1161\/CIRCULATIONAHA.109.912550","article-title":"Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET\/OFFSET study","volume":"120","author":"Gurbel","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.08.016_bb0135","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2016-310897","article-title":"Cardiovascular outcomes with an inhaled beta2-agonist\/corticosteroid in patients with COPD at high cardiovascular risk","author":"Brook","year":"2017","journal-title":"Heart"},{"key":"10.1016\/j.ejim.2017.08.016_bb0140","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(16)30069-1","article-title":"Fluticasone furoate and vilanterol and survival in chronic obstructive pulmonary disease with heightened cardiovascular risk (SUMMIT): a double-blind randomised controlled trial","volume":"387","author":"Vestbo","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2017.08.016_bb0145","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.coph.2015.01.005","article-title":"Glucocorticoids and 11\u03b2-hydroxysteroid dehydrogenases: mechanisms for hypertension","volume":"21","author":"Hunter","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0150","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1210\/en.2015-1604","article-title":"Corticosteroids are essential for maintaining cardiovascular function in male mice","volume":"157","author":"Cruz-Topete","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.ejim.2017.08.016_bb0155","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2174\/157489012803832829","article-title":"Routine use of corticosteroids to prevent inflammation response in cardiac surgery","volume":"7","author":"Nebelsiek","year":"2012","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.1016\/j.ejim.2017.08.016_bb0160","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1001\/archinte.165.14.1643","article-title":"Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock","volume":"165","author":"Kohsaka","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0165","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1164\/ajrccm.155.2.9032192","article-title":"Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD","volume":"155","author":"Keatings","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0170","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1164\/ajrccm.160.5.9811058","article-title":"Effect of high dose inhaled steroid on cells, cytokines, and proteases in induced sputum in chronic obstructive pulmonary disease","volume":"160","author":"Culpitt","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0175","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1161\/01.CIR.100.1.96","article-title":"C-reactive protein as a cardiovascular risk factor: more than an epiphenomenon?","volume":"100","author":"Lagrand","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2017.08.016_bb0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1513\/pats.200406-034MS","article-title":"Effects of corticosteroids on systemic inflammation in chronic obstructive pulmonary disease","volume":"2","author":"Man","year":"2005","journal-title":"Proc Am Thorac Soc"},{"key":"10.1016\/j.ejim.2017.08.016_bb0185","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.2147\/COPD.S91684","article-title":"Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trial","volume":"10","author":"Santus","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.ejim.2017.08.016_bb0190","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1164\/rccm.201508-1647OC","article-title":"Lung deflation and cardiovascular structure and function in chronic obstructive pulmonary disease. A randomized controlled trial","volume":"193","author":"Stone","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0195","article-title":"Fluticasone furoate, vilanterol and lung function decline in patients with moderate COPD and heightened cardiovascular risk","author":"Calverley","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ejim.2017.08.016_bb0200","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0002-9149(87)90817-4","article-title":"Relation between use of anti-inflammatory agents and left ventricular free wall rupture during acute myocardial infarction","volume":"59","author":"Silverman","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0205","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.ijcard.2008.11.021","article-title":"Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry","volume":"140","author":"Campo","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ejim.2017.08.016_bb0210","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","article-title":"Clinical significance of symptoms in smokers with preserved pulmonary function ONLINE","volume":"374","author":"Woodruff","year":"2016","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620517303187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T10:22:13Z","timestamp":1535451733000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620517303187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":42,"alternative-id":["S0953620517303187"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.016","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhaled corticosteroid\/long-acting bronchodilator treatment mitigates STEMI clinical presentation in COPD patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2017.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}